Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Harnessing monocyte-derived macrophages to control central nervous system pathologies: No longer 'if' but 'how'
Alemtuzumab: A new therapy for active relapsing-remitting multiple sclerosis.
A Web-based tool for personalized prediction of long-term disease course in patients with multiple sclerosis.
17β-trenbolone, an anabolic-androgenic steroid as well as an environmental hormone, contributes to neurodegeneration.
Shifting imaging targets in multiple sclerosis: From inflammation to neurodegeneration.
A genome-wide association study in progressive multiple sclerosis.
Interferon-β Suppresses Murine Th1 Cell Function in the Absence of Antigen-Presenting Cells.
Simvastatin: two decades in a circle.
Yoga for multiple sclerosis: a systematic review and meta-analysis.
Comparing routine neurorehabilitation program with trunk exercises based on Bobath concept in multiple sclerosis: Pilot study.
Discovery of Tetrahydropyrazolopyridine as Sphingosine 1-Phosphate Receptor 3 (S1P3)-Sparing S1P1 Agonists Active at Low Oral Doses.
Breastfeeding is associated with lower risk for multiple sclerosis.
A Patient with Leiden V Mutation, Multiple Sclerosis, Psoriasis, and Sicca Syndrome: Could Celecoxib and Fingolimod Adversely Affect the Heart?
MRI characteristics of familial and sporadic multiple sclerosis patients.
Re-engineering of pathogenic aquaporin 4-specific antibodies as molecular decoys to treat neuromyelitis optica.
Differences in Diffusion Tensor Imaging-Derived Metrics in the Corpus Callosum of Patients With Multiple Sclerosis Without and With Gadolinium-Enhancing Cerebral Lesions.
Could Intrathymic Injection of Myelin Basic Protein Suppress Inflammatory Response After Co-culture of T Lymphocytes and BV-2 Microglia Cells?
Pathophysiology of the brain extracellular matrix: a new target for remyelination.
Comparative analysis of first-year fingolimod and natalizumab drug discontinuation among Swedish patients with multiple sclerosis.
[Unified assessment of adverse events of multiple sclerosis disease modifying drugs.]
Posterior brain damage and cognitive impairment in pediatric multiple sclerosis.
Riluzole inhibits spontaneous Ca2+ signaling in neuroendocrine cells by activation of K+ channels and inhibition of Na+ channels.
The analysis of correlation between IL-1B gene expression and genotyping in multiple sclerosis patients.
Cerebrospinal fluid anti-whole myelin antibodies are not correlated to magnetic resonance imaging activity in multiple sclerosis.
Speedy eye movements in multiple sclerosis: Association with performance on visual and nonvisual cognitive tests.

Pages